Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)
Condition: Alcohol Use Disorder (AUD) · Major Depressive Disorder (MDD) · Comorbidities and Coexisting Conditions · Sponsor: South West Sydney Local Health District
About this study
To assess the safety, feasibility and preliminary efficacy of ketamine-enhanced therapy (KET) for alcohol use disorder (AUD) and comorbid major depressive disorder (MDD) in an open-label, single arm, pilot clinical trial.
This description comes directly from the study's public registry record.
Talk to the study team
Kirsten C Morley, PhD · +61295153636 · Kirsten.morley@sydney.edu.au
Ellen Towers · ellen.towers@sydney.edu.au
Always discuss trial participation with your own doctor first.
Locations (1)
| Drug Health Services, Royal Prince Alfred Hospital | Sydney, New South Wales, Australia | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07247370